<DOC>
	<DOCNO>NCT00304161</DOCNO>
	<brief_summary>This study evaluate effectiveness atomoxetine reduce symptom depression people Parkinson 's disease .</brief_summary>
	<brief_title>Effectiveness Antidepressant Treatment Depression People With Parkinson 's Disease</brief_title>
	<detailed_description>Depression serious medical condition affect people 's thought , feeling , ability function everyday life . Depression happen anyone , risk people Parkinson 's disease , progressive brain disorder cause loss dopamine-producing brain cell . As many half people Parkinson 's may suffer depression . These individual experience different symptom depression alone . For example , prone high rate anxiety , sadness without guilt self-blame , low suicide rate despite high rate suicidal thought . Depression treatment help people Parkinson 's disease depress manage disease improve quality life . This study evaluate effectiveness atomoxetine , antidepressant medication , reduce symptom depression people Parkinson 's disease . Participants double-blind study randomly assign receive either atomoxetine placebo 8 week . All participant report study site baseline Weeks 2 , 4 , 8 . Psychiatric , neuropsychological , neurological assessment perform , include evaluation Inventory Depressive Symptomatology ( IDS ) scale Clinical Global Impression-Improvement ( CGI-I ) scale . All participant offer continued routine psychiatric care study physician upon completion study .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Diagnosis idiopathic Parkinson 's disease IDS score great 21 MiniMental State Examination ( MMSE ) score great 15 Recent deep brain stimulation Currently participate antidepressant trial less adequate dose duration Severe depression depression suicide ideation History liver toxicity Unstable medical disease comorbid psychiatric disease</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>Atomoxetine</keyword>
</DOC>